| Wendy C Mcdowell, LCSW | |
|
1310 N Hearne Ave, Shreveport, LA 71107-6516 | |
| (318) 676-5111 | |
| (318) 676-5077 |
| Full Name | Wendy C Mcdowell |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 30 Years |
| Location | 1310 N Hearne Ave, Shreveport, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932252616 | NPI | - | NPPES |
| 3752123 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 4308 (Louisiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Louisiana Human Services District | 1456580398 | 8 |
News Archive
Cancer Research UK scientists in Oxford have found a new way to make prostate cancer succumb more readily to currently used treatments.
According to a random online survey of 2,150 medical device industry professionals between January 4 and January 13, a full 55 percent are looking at 2010 as the year to make a job change.
Cell Therapeutics, Inc. today announced that the North Central Cancer Treatment Group ("NCCTG") plans to conduct a Phase II study of brostallicin in combination with cisplatin in patients with metastatic triple-negative breast ("mTNBC") cancer, defined by tumors lacking expression of estrogen, progesterone receptors and without over-expression of HER2. Additionally, the majority of breast cancers that are associated with the susceptibility mutation (BRCA1) are of the triple-negative type.
New published data from a large pan-European survey indicate that the majority of postmenopausal women with early breast cancer taking post-surgical endocrine therapy are not involved in making key decisions about their treatment, nor are they given sufficient information to make informed treatment choices that could affect their long-term outcome.
A series of 15 scientific papers published this week in the journals of the Genetics Society of America (Genetics and G3: Genes|Genomes|Genetics) put North Carolina at the epicenter of a scientific resource called the Collaborative Cross - a "library" of genetic diversity that scientists believe can help fast-track important discoveries about genetics and disease into new discoveries, tests, and treatments that impact human health.
› Verified 5 days ago
| Entity Name | Northwest Louisiana Human Services District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821421686 PECOS PAC ID: 1456580398 Enrollment ID: O20140412000086 |
News Archive
Cancer Research UK scientists in Oxford have found a new way to make prostate cancer succumb more readily to currently used treatments.
According to a random online survey of 2,150 medical device industry professionals between January 4 and January 13, a full 55 percent are looking at 2010 as the year to make a job change.
Cell Therapeutics, Inc. today announced that the North Central Cancer Treatment Group ("NCCTG") plans to conduct a Phase II study of brostallicin in combination with cisplatin in patients with metastatic triple-negative breast ("mTNBC") cancer, defined by tumors lacking expression of estrogen, progesterone receptors and without over-expression of HER2. Additionally, the majority of breast cancers that are associated with the susceptibility mutation (BRCA1) are of the triple-negative type.
New published data from a large pan-European survey indicate that the majority of postmenopausal women with early breast cancer taking post-surgical endocrine therapy are not involved in making key decisions about their treatment, nor are they given sufficient information to make informed treatment choices that could affect their long-term outcome.
A series of 15 scientific papers published this week in the journals of the Genetics Society of America (Genetics and G3: Genes|Genomes|Genetics) put North Carolina at the epicenter of a scientific resource called the Collaborative Cross - a "library" of genetic diversity that scientists believe can help fast-track important discoveries about genetics and disease into new discoveries, tests, and treatments that impact human health.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wendy C Mcdowell, LCSW 1310 N Hearne Ave, Shreveport, LA 71107-6516 Ph: (318) 676-5111 | Wendy C Mcdowell, LCSW 1310 N Hearne Ave, Shreveport, LA 71107-6516 Ph: (318) 676-5111 |
News Archive
Cancer Research UK scientists in Oxford have found a new way to make prostate cancer succumb more readily to currently used treatments.
According to a random online survey of 2,150 medical device industry professionals between January 4 and January 13, a full 55 percent are looking at 2010 as the year to make a job change.
Cell Therapeutics, Inc. today announced that the North Central Cancer Treatment Group ("NCCTG") plans to conduct a Phase II study of brostallicin in combination with cisplatin in patients with metastatic triple-negative breast ("mTNBC") cancer, defined by tumors lacking expression of estrogen, progesterone receptors and without over-expression of HER2. Additionally, the majority of breast cancers that are associated with the susceptibility mutation (BRCA1) are of the triple-negative type.
New published data from a large pan-European survey indicate that the majority of postmenopausal women with early breast cancer taking post-surgical endocrine therapy are not involved in making key decisions about their treatment, nor are they given sufficient information to make informed treatment choices that could affect their long-term outcome.
A series of 15 scientific papers published this week in the journals of the Genetics Society of America (Genetics and G3: Genes|Genomes|Genetics) put North Carolina at the epicenter of a scientific resource called the Collaborative Cross - a "library" of genetic diversity that scientists believe can help fast-track important discoveries about genetics and disease into new discoveries, tests, and treatments that impact human health.
› Verified 5 days ago
Karl Reichter, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 510 E Stoner Ave, Shreveport, LA 71101 Phone: 319-990-4401 | |
Mrs. Chelsey Vincent, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 856 Texas Ave, Shreveport, LA 71101 Phone: 318-429-6938 | |
Kemeco Taylor-small, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 510 E Stoner Ave, Shreveport, LA 71101 Phone: 318-221-8411 Fax: 318-990-5599 | |
Mr. Dock Voorhies, SOCIAL WORKER Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 510 E Stoner Ave, Shreveport, LA 71101 Phone: 318-424-6040 Fax: 318-424-6121 | |
Danielle Bailey, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 4111 Pines Rd Unit 65, Shreveport, LA 71119 Phone: 318-613-0147 | |
Charles Lee, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6654 Gilbert Pl, Shreveport, LA 71106 Phone: 318-865-4360 | |
Mr. Andrew Wilson, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6007 Financial Plz Ste 213, Shreveport, LA 71129 Phone: 318-458-5158 Fax: 318-220-8108 |